• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素的迭代化学工程产生具有高治疗指数的新型万古霉素类似物。

Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High Therapeutic Index.

作者信息

Mishra Nigam M, Stolarzewicz Izabela, Cannaerts David, Schuermans Joris, Lavigne Rob, Looz Yannick, Landuyt Bart, Schoofs Liliane, Schols Dominique, Paeshuyse Jan, Hickenbotham Peter, Clokie Martha, Luyten Walter, Van der Eycken Erik V, Briers Yves

机构信息

Laboratory for Organic and Microwave-Assisted Chemistry, Department of Chemistry, KU Leuven, Leuven, Belgium.

Department of Chemistry, Warsaw University of Life Sciences, Warsaw, Poland.

出版信息

Front Microbiol. 2018 Jun 7;9:1175. doi: 10.3389/fmicb.2018.01175. eCollection 2018.

DOI:10.3389/fmicb.2018.01175
PMID:29930540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6001238/
Abstract

Vancomycin is a glycopeptide antibiotic that inhibits transpeptidation during cell wall synthesis by binding to the D-Ala-D-Ala termini of lipid II. For long, it has been used as a last resort antibiotic. However, since the emergence of the first vancomycin-resistant enterococci in 1987, vancomycin resistance has become widespread, especially in hospitals. We have synthesized and evaluated 110 vancomycin analogs modified at the C-terminal carboxyl group of the heptapeptide moiety with RNHRNH substituents. Through iterative optimizations of the substituents, we identified vancomycin analogs that fully restore (or even exceed) the original inhibitory activity against vancomycin-resistant enterococci (VRE), vancomycin-intermediate (VISA) and vancomycin-resistant (VRSA) strains. The best analogs have improved growth inhibitory activity and therapeutic indices against a broad set of VRE and methicillin-resistant (MRSA) isolates. They also exceed the activity of vancomycin against ribotypes. Vanc-39 and Vanc-42 have a low probability to provoke antibiotic resistance, and overcome different vancomycin resistance mechanisms (VanA, VanB, and VanC1).

摘要

万古霉素是一种糖肽类抗生素,它通过与脂联素II的D-丙氨酰-D-丙氨酸末端结合来抑制细胞壁合成过程中的转肽作用。长期以来,它一直被用作最后一线抗生素。然而,自1987年首次出现耐万古霉素肠球菌以来,万古霉素耐药性已广泛传播,尤其是在医院。我们合成并评估了110种在七肽部分的C端羧基处用RNHRNH取代基修饰的万古霉素类似物。通过对取代基的迭代优化,我们鉴定出了对耐万古霉素肠球菌(VRE)、万古霉素中介(VISA)和耐万古霉素金黄色葡萄球菌(VRSA)菌株完全恢复(甚至超过)原始抑制活性的万古霉素类似物。最佳类似物对多种VRE和耐甲氧西林金黄色葡萄球菌(MRSA)分离株具有改善的生长抑制活性和治疗指数。它们还超过了万古霉素对不同核糖型的活性。Vanc-39和Vanc-42引发抗生素耐药性的可能性较低,并克服了不同的万古霉素耐药机制(VanA、VanB和VanC1)。

相似文献

1
Iterative Chemical Engineering of Vancomycin Leads to Novel Vancomycin Analogs With a High Therapeutic Index.万古霉素的迭代化学工程产生具有高治疗指数的新型万古霉素类似物。
Front Microbiol. 2018 Jun 7;9:1175. doi: 10.3389/fmicb.2018.01175. eCollection 2018.
2
Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌从医院食品中分离:流行和抗菌药物耐药模式。
Curr Microbiol. 2022 Sep 20;79(11):326. doi: 10.1007/s00284-022-03022-0.
3
Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.麦加霉素:通过对万古霉素进行合理设计而衍生出的耐用抗生素。
Acc Chem Res. 2020 Nov 17;53(11):2587-2599. doi: 10.1021/acs.accounts.0c00569. Epub 2020 Nov 2.
4
[Detection methods for drug-resistant bacteria in routine examination--VISA].常规检查中耐多药菌的检测方法——万古霉素中介金黄色葡萄球菌(VISA)
Rinsho Byori. 2000 Jan;Suppl 111:69-74.
5
Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.意大利临床实验室运用常规实验室方法检测肠球菌和葡萄球菌属中糖肽敏感性降低情况的能力。
Clin Microbiol Infect. 2002 Feb;8(2):101-11. doi: 10.1046/j.1469-0691.2002.00378.x.
6
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.奥利万星及对照药物对金黄色葡萄球菌、粪肠球菌和屎肠球菌的时间杀菌动力学
J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15.
7
Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.印度北部一家三级护理医院出现耐万古霉素金黄色葡萄球菌(VRSA)。
BMC Infect Dis. 2006 Oct 26;6:156. doi: 10.1186/1471-2334-6-156.
8
Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.伊朗西北部从临床标本中分离出的耐甲氧西林金黄色葡萄球菌中出现了万古霉素中介和耐药金黄色葡萄球菌。
J Glob Antimicrob Resist. 2018 Sep;14:4-9. doi: 10.1016/j.jgar.2018.01.017. Epub 2018 Feb 14.
9
Vancomycin Resistance in 
.万古霉素耐药性在……中
Yale J Biol Med. 2017 Jun 23;90(2):269-281. eCollection 2017 Jun.
10
Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms.金黄色葡萄球菌对万古霉素的敏感性降低及耐药性:全球发病率模式及相关遗传机制综述
Cureus. 2021 Oct 20;13(10):e18925. doi: 10.7759/cureus.18925. eCollection 2021 Oct.

引用本文的文献

1
New Conjugates of Vancomycin with Cell-Penetrating Peptides-Synthesis, Antimicrobial Activity, Cytotoxicity, and BBB Permeability Studies.万古霉素与细胞穿透肽的新型缀合物——合成、抗菌活性、细胞毒性及血脑屏障通透性研究
Molecules. 2024 Nov 22;29(23):5519. doi: 10.3390/molecules29235519.
2
The structure of lipopeptides impacts their antiviral activity and mode of action against SARS-CoV-2 .脂肽的结构影响其抗 SARS-CoV-2 的抗病毒活性和作用模式。
Appl Environ Microbiol. 2024 Nov 20;90(11):e0103624. doi: 10.1128/aem.01036-24. Epub 2024 Oct 24.
3
Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria.

本文引用的文献

1
Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics.一系列半合成多环糖肽抗生素的构效关系
Russ J Bioorg Chem. 2006;32(4):303-322. doi: 10.1134/S1068162006040017.
2
Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures.对万古霉素与细菌细胞壁结构之间关键相互作用的见解
ACS Omega. 2018 Jan 31;3(1):37-45. doi: 10.1021/acsomega.7b01483. Epub 2018 Jan 4.
3
Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
变形牛环连接万古霉素二聚体作为有效抗生素对抗多重耐药革兰阳性菌。
Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2208737120. doi: 10.1073/pnas.2208737120. Epub 2023 Apr 3.
4
Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.近年来半合成糖肽类抗生素的研究进展:2014-2022 年。
ACS Infect Dis. 2022 Aug 12;8(8):1381-1407. doi: 10.1021/acsinfecdis.2c00253. Epub 2022 Jul 27.
5
Bacterial Antibiotic Resistance: The Most Critical Pathogens.细菌抗生素耐药性:最关键的病原体。
Pathogens. 2021 Oct 12;10(10):1310. doi: 10.3390/pathogens10101310.
6
Alternatives to Fight Vancomycin-Resistant and .对抗耐万古霉素的替代方法及…… (原文不完整,翻译可能不太准确)
Antibiotics (Basel). 2021 Sep 16;10(9):1116. doi: 10.3390/antibiotics10091116.
7
Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete.化学转录组分析确定了VanB型耐药链霉菌中糖肽类抗生素达巴万星、万古霉素和氯联苯万古霉素的药物特异性特征。
Front Microbiol. 2021 Feb 25;12:641756. doi: 10.3389/fmicb.2021.641756. eCollection 2021.
8
The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant Bacteriolysis.抗葡萄球菌溶素 CF-301 在人血中激活关键宿主因子增强耐甲氧西林金黄色葡萄球菌裂解。
Antimicrob Agents Chemother. 2019 Mar 27;63(4). doi: 10.1128/AAC.02291-18. Print 2019 Apr.
万古霉素上的额外糖分:用于对抗耐多药金黄色葡萄球菌和万古霉素耐药肠球菌的新类似物。
J Med Chem. 2018 Jan 11;61(1):286-304. doi: 10.1021/acs.jmedchem.7b01345. Epub 2018 Jan 2.
4
Design, Synthesis, and the Biological Evaluation of a New Series of Acyclic 1,2,3-Triazole Nucleosides.新型无环 1,2,3-三唑核苷的设计、合成与生物评价。
Arch Pharm (Weinheim). 2017 Sep;350(9). doi: 10.1002/ardp.201700166. Epub 2017 Aug 1.
5
Peripheral modifications of [Ψ[CHNH]Tpg]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics.通过对[Ψ[CHNH]Tpg]万古霉素进行外围修饰,并增加协同作用机制,提供了持久而有效的抗生素。
Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5052-E5061. doi: 10.1073/pnas.1704125114. Epub 2017 May 30.
6
Total Syntheses of Vancomycin-Related Glycopeptide Antibiotics and Key Analogues.万古霉素相关糖肽类抗生素及关键类似物的全合成
Chem Rev. 2017 Sep 27;117(18):11952-11993. doi: 10.1021/acs.chemrev.6b00820. Epub 2017 Apr 24.
7
Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers.评估具有不同连接子的新型CRAMP-万古霉素缀合物的抗菌和抗生物膜活性。
Org Biomol Chem. 2015 Jul 21;13(27):7477-86. doi: 10.1039/c5ob00830a.
8
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.膜活性万古霉素类似物:一种应对细菌耐药性的策略。
J Med Chem. 2014 Jun 12;57(11):4558-68. doi: 10.1021/jm500270w. Epub 2014 May 20.
9
Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.探讨万古霉素 E 环芳基氯的作用:选择性的发散合成和替代 E 环类似物的评估。
J Med Chem. 2013 May 23;56(10):4116-24. doi: 10.1021/jm4004494. Epub 2013 May 13.
10
Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.苯并恶唑硼酸酯偶联的抗菌糖肽抗生素的合成与抗菌活性研究。
Future Med Chem. 2013 Apr;5(6):641-52. doi: 10.4155/fmc.13.16.